Edity Therapeutics, a first-in-category cellular delivery company, announced today that Abigail Bracha, PhD, has joined as President.
Read more here.
Edity Therapeutics, a first-in-category cellular delivery company, announced today that Abigail Bracha, PhD, has joined as President.
Read more here.
![[prooV in PR Newswire] prooV is Recognized by Frost & Sullivan for Leading the Way with Its Innovative Proof-of-Concept Service Platform](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
